Joe Cohen

Joe Cohen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joe Cohen sits on this spectrum.

Joe Cohen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joe Cohen sits on this spectrum.

Research.com Recognitions

• 1999 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Best Publications

• A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

  J A Stoute;M Slaoui;D G Heppner;P Momin

  1345
  Citations

• First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

  Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar

  1235
  Citations

• Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

  Pedro L. Alonso;Jahit Sacarlal;John J. Aponte;Amanda J Leach

  1021
  Citations

• Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

  Kent E. Kester;James F. Cummings;Opokua Ofori-Anyinam;Christian F. Ockenhouse

  724
  Citations

• A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

  Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes

  717
  Citations

• Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

  Kalifa A. Bojang;Paul J. M. Milligan;Margaret Pinder;Laurence Vigneron

  690
  Citations

• Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

  Pedro L Alonso;Jahit Sacarlal;John J Aponte;Amanda Leach

  560
  Citations

• Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

  Philip Bejon;John Lusingu;Ally Olotu;Amanda Leach

  550
  Citations

• A field trial to assess a blood-Stage malaria vaccine

  Mahamadou A. Thera;Ogobara K. Doumbo;Drissa Coulibaly;Matthew B. Laurens

  443
  Citations

• Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.

  Bernhards R. Ogutu;Odika J. Apollo;Denise McKinney;Willis Okoth

  382
  Citations

• Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

  John J Aponte;John J Aponte;Pedro Aide;Montse Renom;Montse Renom;Inacio Mandomando

  353
  Citations

• Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

  Kent E. Kester;Denise A. McKinney;Nadia Tornieporth;Christian F. Ockenhouse

  353
  Citations

• A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.

  William H H Reece;Margaret Pinder;Philip K Gothard;Paul Milligan

  341
  Citations

• From the circumsporozoite protein to the RTS, S/AS candidate vaccine.

  Joe Cohen;Victor Nussenzweig;Ruth Nussenzweig;Johan Vekemans

  327
  Citations

• Long-Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

  J A Stoute;K E Kester;U Krzych;B T Wellde

  326
  Citations

• Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

  Salim Abdulla;Rolf Oberholzer;Rolf Oberholzer;Omar Juma;Sulende Kubhoja

  321
  Citations

• Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ

  Peifang Sun;Robert Schwenk;Katherine White;Jose A. Stoute

  301
  Citations

• Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

  D. Gray Heppner;Kent E. Kester;Christian F. Ockenhouse;Nadia Tornieporth

  257
  Citations

• Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

  Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta

  240
  Citations

• Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

  Jason A. Regules;Susan B. Cicatelli;Jason W. Bennett;Kristopher M. Paolino

  238
  Citations

• Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

  Ally Olotu;John Lusingu;John Lusingu;Amanda Leach;Marc Lievens

  232
  Citations